Single use downstream bioprocessing includes technologies and consumables used in purification and detection steps after the primary cultivation of cells in downstream processing. It offers advantages such as reducing capital costs, labor, utilities and operational expenditure. Single use technologies eliminate the requirement for costly cleaning, cleaning validation, hold time and assembly/disassembly between production campaigns. The single use systems offer flexibility, scalability and a quick time to market. The growing focus on reducing capital costs in bioprocessing is driving the demand for single use technologies.
The Single Use Downstream Bioprocessing Market is estimated to be valued at US$ 1.51 Billion in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the single use downstream bioprocessing are 3M, Agilitech, CPC (Colder Products Company), Cytiva Lifesciences, Pall Corporation and Among Others. The key players are focusing on new product launches and expansion strategies to gain a competitive edge in the market. For instance, in 2022, Cytiva launched the Sartopore Maxiplus membrane adsorber, a single-use device.
The market is witnessing high growth in demand due to rising demand for biologics. Biopharmaceutical products are increasingly preferred over conventional drugs due to their high specificity and efficacy. Growth in biologics production is fueling the demand for downstream bioprocessing technologies including single use systems.
Technological advancements are supporting the adoption of single use technologies. Key players are focusing on developing single use systems with advanced functionality, automation and integration capabilities. This is helping to reduce operational costs and improve process efficiency in biopharmaceutical manufacturing.
Market Trends
Increasing outsourcing of bioprocessing activities: Growing capital requirements and complexities are driving biopharmaceutical manufacturers to outsource bioprocessing steps. This is increasing the adoption of flexible single use systems by contract development and manufacturing organizations.
Integration of analytics and digital solutions: Vendors are focusing on integrating analytics and digital solutions with single use systems. This is helping to monitor processes in real-time, optimize operations and ensure process consistency across biomanufacturing facilities.
Market Opportunities
Increasing demand for biologics in emerging markets: Emerging countries in Asia Pacific and Latin America are witnessing rising healthcare expenditure and demand for biologic drugs. This provides opportunities for single use bioprocessing system manufacturers to expand in emerging markets.
Adoption in cell and gene therapies: Single use technologies are increasingly being adopted in the manufacturing of advanced therapy medicines including cell and gene therapies. Their scalable and modular nature addresses the manufacturing challenges in these highly potent therapies.
Impact Of COVID-19 On Single Use Downstream Bioprocessing Market Growth
The COVID-19 pandemic has adversely impacted the single use downstream bioprocessing market growth. During the initial phases of the pandemic, there was disruptions in supply chains and shortage of raw materials which resulted in delay or halt of bioprocessing operations. However, as the pandemic intensified, the demand for bioprocessing surged as more resources were directed towards development of vaccines and therapeutics. Manufacturers responded by ramping up production capacity and opting for single use technologies to ensure agile operations. Single use systems allow for quick scale up/down during demand fluctuations offering flexibility. Their implementation reduces turnaround time and facilitates remote operations.
Post pandemic, the market is expected to witness sustained growth driven by the legacy of COVID-19. There is higher focus on pandemic preparedness which will bolster investments in bioprocessing infrastructure and capacity. Adoption of single use technologies is likely to grow further as their advantages become more evident. Manufacturers will give preference to single use systems for their scalability, safety and reduced costs. Regulatory agencies are also positive about single use production systems. The pandemic has highlighted the need for resilient and responsive supply chains which single use bioprocessing perfectly addresses.
Geographical Regions With Highest Value For Single Use Downstreaming Market
North America currently dominates the single use downstream bioprocessing market in terms of value. Presence of leading biologics manufacturers, increasing demand for biotherapeutics and advanced bioprocessing infrastructure has propelled market growth in the region. In addition, supportive regulatory environment and heavy investments in R&D of novel drugs have augmented regional market. Europe is another major revenue generator attributing to rising biopharmaceutical spending, healthcare reforms and growing biologics acceptance. Countries like Germany, France and UK are major European hubs for biologics production contributing significantly.
Asia Pacific represents the fastest growing regional market for single use downstream bioprocessing. Factors such as improving healthcare infrastructure, favorable FDI policies, low manufacturing costs and rising chronic disease burden are favoring market expansion. Countries like China, India and South Korea are witnessing rapid economic growth and increasing biotechnology investments which is positively impacting the regional market. Additionally, shift of biopharma operations from developed markets to Asia Pacific will further stimulate future market opportunities.
Get more insights on this topic: https://www.trendingwebwire.com/single-use-downstream-bioprocessing-market-to-witnesses-high-growth-due-to-advancements-in-disposable-technology/
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )
What Are The Key Data Covered In This Single Use Downstream Bioprocessing Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Single Use Downstream Bioprocessing's growth between 2024 and 2031.
:- Accurate calculation of the size of the Single Use Downstream Bioprocessing and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Single Use Downstream Bioprocessing Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Single Use Downstream Bioprocessing vendors
FAQ’s
Q.1 What are the main factors influencing the Single Use Downstream Bioprocessing?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Single Use Downstream Bioprocessing companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Single Use Downstream Bioprocessing’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Comments
0 comment